Chemokines as potential markers in pediatric renal diseases

Ana Cristina Simões e Silva1, André Barreto Pereira2, Mauro Martins Teixeira3

  • 1Unidade de Nefrologia Pediátrica, Departamento de Pediatria, Universidade Federal de Minas Gerais (UFMG), 30130-100 Belo Horizonte, MG, Brazil ; Instituto Nacional de Ciência e Tecnologia em Medicina Molecular (INCT-MM), Faculdade de Medicina, UFMG, 30130-100 Belo Horizonte, MG, Brazil ; Laboratório Interdisciplinar de Investigação Médica Faculdade de Medicina, UFMG, Avenida Alfredo Balena 190, 2nd Floor, Room No.281, 30130-100 Belo Horizonte, MG, Brazil.

Disease Markers
|April 3, 2014
PubMed

Insights

Chemokines show promise as biomarkers for diagnosing pediatric kidney diseases. Evaluating these inflammatory molecules may aid in managing childhood renal diseases and identifying those at risk for chronic kidney disease (CKD).

Area of Science:

  • Pediatric Nephrology
  • Renal Pathophysiology
  • Biomarker Discovery

Background:

  • Chronic kidney disease (CKD) in children is frequently caused by glomerular diseases and obstructive uropathies.
  • Biomarkers are increasingly researched for diagnosing pediatric renal conditions.
  • Chemokines are inflammatory mediators implicated in the pathophysiology of various pediatric renal diseases.

Purpose of the Study:

  • To review general aspects of chemokines.
  • To explore the potential link between chemokines and common pediatric renal diseases.
  • To synthesize experimental and clinical evidence regarding chemokines in pediatric kidney disease.

Main Methods:

  • Literature review of chemokines.
  • Analysis of experimental data on chemokines in renal disease models.
  • Examination of clinical studies investigating chemokines in pediatric patients with kidney diseases.

Main Results:

  • Chemokines play significant roles in the development and progression of pediatric renal diseases.
  • Specific chemokines may serve as valuable diagnostic or prognostic markers.
  • Evidence suggests chemokines are involved in the inflammatory processes underlying common childhood kidney conditions.

Conclusions:

  • Chemokines represent a promising class of biomarkers for pediatric renal diseases.
  • Further research into chemokines could improve diagnosis, risk stratification, and management of CKD in children.
  • Evaluating chemokine profiles may offer new therapeutic targets for pediatric kidney disorders.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
408
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
559
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
410
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
1.1K
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
2.3K
Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate01:25

Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate

The glomerular filtration rate (GFR) is a critical indicator of kidney health, reflecting how well the kidneys filter blood. Changes in GFR can signal potential kidney impairment, necessitating accurate measurement methods to monitor kidney function effectively.Various molecules can serve as markers for GFR measurement, with the ideal marker meeting several specific criteria. It must freely filter at the glomerulus, avoid reabsorption or secretion by the renal tubules, remain unmetabolized, not...
143